Muscle Loss: Clinical Trials

6 trials for Muscle Loss, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 6
Phase 11Completed 1
Phase 31Completed 1

Follow Muscle Loss: new trials by email Literature Review of Muscle Loss trials Research Report on Muscle Loss

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt
Enobosarm, Semaglutide - Muscle Loss, Obesity
Phase 2CompletedVeru Inc.1682024-04-292025-09-17
Pediatric Oncology Nutrition Intervention Trial
Oral Nutrition Supplement, Tube Feed, Cyproheptadine - Pediatric Cancer, Nutrition Related Cancer
Phase 2 / Phase 3CompletedCorey Hawes202024-01-312026-10-08
Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)
Ursolic Acid, Strength Training - Spinal Cord Injuries, Tetraplegia
Phase 2CompletedUniversity of Miami102023-03-272025-05-21
Effect of High Protein Diet in Stroke Patients With Low Muscle Mass
high protein diet, normal protein diet - Ischemic Stroke, Diet, Healthy
Phase 2CompletedChang Gung Memorial Hospital1102017-12-152023-03-30
Musculoskeletal Effects of Bicarbonate
potassium bicarbonate, Inactive placebo capsule - Muscle Loss, Fractures
Phase 2CompletedTufts University2442012-01-012015-10-19
Essential Amino Acids Supplementation and Muscle Protein Synthesis
Essential Amino Acids, Endurance exercise - Muscle Loss, Muscle Anabolism
Phase 1 / Phase 2CompletedUnited States Army Research Institute of Environmental Medicine232007-05-012017-07-21

Narrower conditions

Muscular Atrophy (6)  ·  Child Nutrition Disorders (1)  ·  Fractures, Bone (1)  ·  Insulin Resistance (1)  ·  Ischemic Stroke (1)  ·  Neoplasms (1)  ·  Obesity (1)  ·  Osteoporosis (1)  ·  Paraplegia (1)  ·  Quadriplegia (1)  ·  Spinal Cord Injuries (1)

Broader conditions

Atrophy (6)  ·  Nervous System Diseases (6)  ·  Neurologic Manifestations (6)  ·  Neuromuscular Manifestations (6)  ·  Pathological Conditions, Anatomical (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Signs and Symptoms (6)  ·  Nutritional and Metabolic Diseases (4)  ·  Central Nervous System Diseases (2)  ·  Metabolic Diseases (2)  ·  Nutrition Disorders (2)  ·  Wounds and Injuries (2)  ·  Body Weight (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)

Interventions

Amino Acids, Essential (1)  ·  Cyproheptadine (1)  ·  Diet, High-Protein (1)  ·  Enteral Nutrition (1)  ·  Olanzapine (1)  ·  Resistance Training (1)  ·  Standard of Care (1)  ·  Ursolic Acid (1)  ·  ostarine (1)  ·  potassium bicarbonate (1)  ·  semaglutide (1)

Sponsors

Chang Gung Memorial Hospital (1)  ·  Corey Hawes (1)  ·  Tufts University (1)  ·  United States Army Research Institute of Environmental Medicine (1)  ·  University of Miami (1)  ·  Veru Inc. (1)

Countries

United States (5)  ·  Taiwan (1)

Top investigators

Bess Dawson-Hughes, M.D. (1)  ·  Corey J Hawes, DCN, RD, CSO, CNSC, LD (1)  ·  Mark S Nash, PhD (1)  ·  Stefan M Pasiakos, Ph.D. (1)

Results publications

PMID 20739716, PMID 21389329, PMID 28842733, PMID 29211866

NIH funding

R01AR060261 (1), UL1TR001998 (1)